CA
NZ
UK
AU
IND
US
Hinge Health, Inc. (NYSE: HNGE) has entered into a significant office lease agreement, committing to approximately $86 million for office space measuring 119,278 rentable square feet at 300 Mission Street in San Francisco. The lease is slated to commence fiveBusinessdays following its execution. This …
Siegfried Holding AG reported growth in adjustedEarningsduring its Q2 2026 earnings call, reflecting strategic operational adjustments. This resilience signals to investors a robust response to market dynamics that may enhance profitability going forward.Key HighlightsSiegfried Holding AG indicated a notable growth trend in adjusted earnings, …
This filing is key for MANNKIND CORP (NASDAQ: MNKD), as it allows for an expanded strategy in securing funding and managing financial operations. By enhancing its registration capabilities, MannKind opens pathways for future fundraising efforts, possibly engaging new investors looking for opportunities in the …
Despite this growth, Paxman AB (publ) (OTC: PXMBF) continues to grapple with a net margin of -1.4%, signaling potential challenges in maintaining profitability. Such performance raises questions for investors regarding the sustainability of revenue increases against operational costs. The lack ofEarnings Per Shareimprovement compared …
This development, finalized on August 19, 2026, positions Apimeds toCapitalizeon the growingDemandfor Apitox in Korea, particularly in specialized clinical settings. As part of the assignment agreement with FreeT Inc. Apimeds Pharmaceuticals US, Inc. (AMEX: APUS) has secured one hundred percent (100%) of the rights …
Elutia Inc. (NASDAQ: ELUT) has successfully completed the sale of its SimpliDerm business to Cellution Biologics Inc. for total proceeds potentially reaching $11 million. The transaction, which closed on August 17, 2026, includes approximately $7.7 million delivered to Elutia immediately, with additional contingent payments …
Moderna Inc. (NASDAQ: MRNA) is a leading biotechnology company with a marketCapitalizationof $25.1 billion, specializing in mRNA technology. Recently, the firm's share price soared 129% week-on-week after it achieved groundbreaking results in a clinical trial for its melanoma therapy in collaboration with Merck. The …
Starling Oncology, Inc. has entered into a new credit agreement enabling it to access a revolving line of credit facility totaling up to $25 million. This agreement aims to provide the company with additional financial flexibility, essential for managing its operational needs and enhancing …
This tender offer signifies a direct response to the support of its investors as Arbutus seeks to leverage its financial gains.
Alpha Teknova reported record second-quarterRevenueof $12.2 million, an 18% year-over-year increase, and raised its full-year revenue guidance to between $45 million and $47 million. This upward revision signals momentum in biopharma funding and custom solution offerings, which could attract investor interest.Key HighlightsSecond-quarter revenue of …
Please wait processing your request...